| y2gzPembrolizumab+GEM+CDDPΓ@ | |||||||||||||||||||||||||||||||
| ΪΌ | ξΚ | PΚ | }¦ | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | |||||||
| SΜXPW [ | | x | x | x | x | x | x | -- | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||
| LCg[_ | 200 | mg | | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | ||||||||
| VXv` | 25 | mg/u | | @ | @ | @ | @ | @ | @ | | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | ||||||||
| QV^r | 1000 | mg/u | | @ | @ | @ | @ | @ | @ | | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | @ | ||||||||
| yΣz | |||||||||||||||||||||||||||||||